Fwd: Recommended articles
3 views
Skip to first unread message
Okechukwu Ogah
May 27, 2024, 12:15:32 AMMay 27
to nigerian-car...@googlegroups.com
Dr O.S Ogah. MBBS, MSc, PhD, MD, FWACP, FACP, FESC, FNCS
A. Senior Lecturer
Cardiology Unit, Department of Medicine,
Faculty of Clinical Sciences
College of Medicine,
University of Ibadan, NIGERIA
B. Honorary Consultant Physician/Cardiologist,
Cardiology Unit,
Department of Medicine
University College Hospital Ibadan, NIGERIA
PERSONAL POSTAL ADDRESS
P.O BOX 14343, UNIVERSITY OF IBADAN POST OFFICE
IBADAN, NIGERIA
C. Bernard Lown Visiting Scholar in Cardiovascular Health
Department of Global Health and Population
Harvard T.H. Chan School of Public Health
Email: oo...@hsph.harvard.edu
D. Adjunct Researcher,
Institute of Advanced Medical Research and Training (IAMRAT)
College of Medicine, University of Ibadan, NIGERIA
E. Affiliate Member,
The Hatter Institute for Cardiovascular Research in Africa (HICRA)
4th Floor Chris Barnard Building
Faculty of Health Sciences
University of Cape Town
Private Bag X3 7935
Observatory, SOUTH AFRICA
Faculty of Health Sciences
University of Cape Town
Private Bag X3 7935
Observatory, SOUTH AFRICA
F. Past President,
Nigerian Cardiac Society
--------------------------------------------------------------------------------------------------------------------------------------------------
"For with thee is the fountain of life: in thy light shall we see light." Psalm 36:9
-------------------------------------------------------------------------------------------------
---------- Forwarded message ---------
From: Google Scholar Alerts <scholarale...@google.com>
Date: Sun, May 26, 2024 at 9:51 PM
Subject: Recommended articles
To: <osoga...@gmail.com>
From: Google Scholar Alerts <scholarale...@google.com>
Date: Sun, May 26, 2024 at 9:51 PM
Subject: Recommended articles
To: <osoga...@gmail.com>
[HTML] A study protocol to characterise pathophysiological and molecular markers of rheumatic heart disease and degenerative aortic stenosis using multiparametric …
DW Mutithu, OO Aremu, D Mokaila, T Bana, M Familusi… - Plos one, 2024
Introduction Rheumatic heart disease (RHD), degenerative aortic stenosis (AS), and
congenital valve diseases are prevalent in sub-Saharan Africa. Many knowledge
gaps remain in understanding disease mechanisms, stratifying phenotypes, and …
congenital valve diseases are prevalent in sub-Saharan Africa. Many knowledge
gaps remain in understanding disease mechanisms, stratifying phenotypes, and …
 |  |  |  |
Lifestyle Intervention Improves Parasympathetic Activity in Hypertrophic Cardiomyopathy
AI Alyahya, SJ Charman, NC Okwose, AS Fuller… - American Journal of …, 2024
Background A limited number of studies have investigated the effects of lifestyle
interventions in hypertrophic cardiomyopathy (HCM). This study evaluated the effect
of a novel lifestyle intervention incorporating physical activity (PA) and dietary nitrate …
interventions in hypertrophic cardiomyopathy (HCM). This study evaluated the effect
of a novel lifestyle intervention incorporating physical activity (PA) and dietary nitrate …
| | | |
[PDF] Impact of Anatomical and Viability-guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
SM Ezad, M McEntegart, M Dodd, M Didagelos, N Sidik… - Journal of the American …, 2024
Background Complete revascularization of coronary disease has been linked to
improved outcomes in patients with preserved left ventricular (LV) function.
Objectives To identify the impact of complete revascularization in patients with …
improved outcomes in patients with preserved left ventricular (LV) function.
Objectives To identify the impact of complete revascularization in patients with …
| | | |
More attention needs to focus on the diabetic cardiomyopathy without coronary artery disease
M Yan, H Fu, X Zhang, K Xu, Y Guo, H Xu - International Journal of Cardiology, 2024
Diabetes mellitus is one of the most common chronic diseases, which has a high
prevalence of 10.5% in 20–79-year-old adults according to the epidemiological
investigation of the 10 th IDF diabetes atlas [1]. Diabetes is a systematic disease …
prevalence of 10.5% in 20–79-year-old adults according to the epidemiological
investigation of the 10 th IDF diabetes atlas [1]. Diabetes is a systematic disease …
| | | |
Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome
W He, J Wei, X Liu, Z Zhang, R Huang, Z Jiang - Scientific reports, 2024
Pathological cardiac hypertrophy is an important cause of heart failure (HF). Recent
studies reveal that glucagon-like peptide-1 receptor (GLP1R) agonists can improve
mortality and left ventricular ejection fraction in the patients with type 2 diabetes and …
studies reveal that glucagon-like peptide-1 receptor (GLP1R) agonists can improve
mortality and left ventricular ejection fraction in the patients with type 2 diabetes and …
| | | |
See all recommendations
This message was sent by Google Scholar because you're following new recommended articles for your profile.
Okechukwu Ogah
May 29, 2024, 5:10:50 PMMay 29
to nigerian-car...@googlegroups.com
[PDF] Hyperlactataemia is a marker of reduced exercise capacity in heart failure with preserved ejection fraction
E Nan Tie, E Wolsk, S Nanayakkara, D Vizi, J Mariani… - ESC Heart Failure, 2024
Aims Heart failure with preserved ejection fraction (HFpEF) is associated with an
array of central and peripheral haemodynamic and metabolic changes. The exact
pathogenesis of exercise limitation in HFpEF remains uncertain. Our aim was to …
array of central and peripheral haemodynamic and metabolic changes. The exact
pathogenesis of exercise limitation in HFpEF remains uncertain. Our aim was to …
| | | |
[PDF] Validation of a New Scoring Method to Assess the Efficacy of Rapid Initiation and Titration of Combination Pharmacotherapy for Patients Hospitalized with Acute …
T Asano, Y Maeno, M Nakano, M Taguri, M Miyasaka… - Journal of Clinical Medicine, 2024
Background: Despite the encouragement of early initiation and titration of guideline-
directed medical therapy (GDMT) for the treatment of heart failure (HF), most patients
do not receive an adequate type and dose of pharmacotherapy in the real world …
directed medical therapy (GDMT) for the treatment of heart failure (HF), most patients
do not receive an adequate type and dose of pharmacotherapy in the real world …
| | | |
[HTML] Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome
W He, J Wei, X Liu, Z Zhang, R Huang, Z Jiang - Scientific Reports, 2024
Pathological cardiac hypertrophy is an important cause of heart failure (HF). Recent
studies reveal that glucagon-like peptide-1 receptor (GLP1R) agonists can improve
mortality and left ventricular ejection fraction in the patients with type 2 diabetes and …
studies reveal that glucagon-like peptide-1 receptor (GLP1R) agonists can improve
mortality and left ventricular ejection fraction in the patients with type 2 diabetes and …
| | | |
[PDF] Electrocardiographic Abnormalities in Nigerian Hypertensives With Echocardiographic Left Ventricular Hypertrophy
OO Abiodun, T Anya, VT Adekanmbi, V Adekanmbi - Cureus, 2024
To enhance the diagnosis of anatomic left ventricular hypertrophy (LVH) using
electrocardiography (ECG), we aimed to identify common ECG amplitude and non-
amplitude abnormalities in Nigerian patients with hypertensive echocardiographic …
electrocardiography (ECG), we aimed to identify common ECG amplitude and non-
amplitude abnormalities in Nigerian patients with hypertensive echocardiographic …
Reply all
Reply to author
Forward
0 new messages